ECSP045123A - Composición para catéteres y sus usos - Google Patents

Composición para catéteres y sus usos

Info

Publication number
ECSP045123A
ECSP045123A EC2004005123A ECSP045123A ECSP045123A EC SP045123 A ECSP045123 A EC SP045123A EC 2004005123 A EC2004005123 A EC 2004005123A EC SP045123 A ECSP045123 A EC SP045123A EC SP045123 A ECSP045123 A EC SP045123A
Authority
EC
Ecuador
Prior art keywords
composition
amount
catheters
efficacy
fibrin
Prior art date
Application number
EC2004005123A
Other languages
English (en)
Inventor
Charles P Sembra
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ECSP045123A publication Critical patent/ECSP045123A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición útil para retirar coágulos de sangre relacionados con la fibrina de un catéter, composición que contiene agua, una cantidad con eficacia fibrinolítica de un activador del plasminógeno, y una cantidad de alcohol orgánico bacteriostático con eficacia preservativa. La composición no incluye un agente quelante.
EC2004005123A 2001-11-26 2004-05-26 Composición para catéteres y sus usos ECSP045123A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
ECSP045123A true ECSP045123A (es) 2004-07-23

Family

ID=23302492

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2004005123F ECSDI045123S (es) 2001-11-26 2004-05-26
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2004005123F ECSDI045123S (es) 2001-11-26 2004-05-26

Country Status (28)

Country Link
US (3) US20030206906A1 (es)
EP (1) EP1455858A4 (es)
JP (1) JP4458240B2 (es)
KR (2) KR20040054803A (es)
CN (1) CN100478027C (es)
AR (1) AR037437A1 (es)
AU (2) AU2002365408B2 (es)
BR (1) BR0215098A (es)
CA (1) CA2467645C (es)
CO (1) CO5580795A2 (es)
EA (1) EA007594B1 (es)
EC (2) ECSDI045123S (es)
HR (1) HRP20040502A2 (es)
HU (1) HUP0600436A3 (es)
IL (2) IL162083A0 (es)
IS (1) IS7275A (es)
ME (1) ME00015B (es)
MX (1) MXPA04004948A (es)
MY (1) MY140404A (es)
NO (1) NO331700B1 (es)
NZ (1) NZ533029A (es)
PL (1) PL371760A1 (es)
RS (1) RS46204A (es)
TW (1) TWI262794B (es)
UA (1) UA81235C2 (es)
UY (1) UY27550A1 (es)
WO (1) WO2003045466A2 (es)
ZA (1) ZA200404024B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS46204A (sr) * 2001-11-26 2006-10-27 Genentech Inc. Preparat za kateter i njegova upotreba
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
WO2008026999A2 (en) * 2006-08-28 2008-03-06 Omnio Healer Ab Candidates against infection
WO2008027000A2 (en) * 2006-08-28 2008-03-06 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
EP2711024B1 (en) * 2007-09-07 2019-03-06 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484A7 (fi) 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
AU7998091A (en) * 1990-05-17 1991-12-10 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
DE69333127T2 (de) * 1992-06-03 2004-05-06 Genentech, Inc., South San Francisco Varianten des Gewebeplasminogenaktivators mit verbesserter therapeutischer Wirkung
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
NZ276633A (en) 1993-11-24 1998-04-27 Du Pont Merck Pharma Isoxazole and isoxazoline derivatives and pharmaceutical compositions thereof
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
WO1998028326A1 (en) 1996-12-23 1998-07-02 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
CA2364252A1 (en) 1999-03-11 2000-09-14 Bristol-Myers Squibb Pharma Company Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
KR20020005614A (ko) 1999-03-11 2002-01-17 블레어 큐. 퍼거슨 Ｘａ 인자 저해제와 아스피린, 조직 플라스미노겐활성화인자(ＴＰＡ), ＧＰⅡｂ／Ⅲａ 길항제, 저분자량헤파린 또는 헤파린의 병용에 의한 혈전증 치료
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
WO2001085249A1 (en) 2000-05-10 2001-11-15 Ash Medical Systems, Inc. A catheter lock solution including a photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
RS46204A (sr) 2001-11-26 2006-10-27 Genentech Inc. Preparat za kateter i njegova upotreba
US20070014779A1 (en) 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
DE60311958T2 (de) 2003-02-03 2007-11-08 Polaschegg, Hans-Dietrich, Dr. Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Also Published As

Publication number Publication date
NO20042693L (no) 2004-08-25
US20030206906A1 (en) 2003-11-06
HRP20040502A2 (en) 2004-12-31
EP1455858A2 (en) 2004-09-15
AU2008203131A1 (en) 2008-08-07
TW200303743A (en) 2003-09-16
CN1617738A (zh) 2005-05-18
KR20100102745A (ko) 2010-09-24
NZ533029A (en) 2006-05-26
NO331700B1 (no) 2012-02-27
MEP8008A (xx) 2010-02-10
UA81235C2 (en) 2007-12-25
MY140404A (en) 2009-12-31
US20060257390A1 (en) 2006-11-16
AU2002365408A1 (en) 2003-06-10
AU2002365408B2 (en) 2008-04-24
RS46204A (sr) 2006-10-27
ZA200404024B (en) 2005-07-27
IL162083A (en) 2012-12-31
CA2467645C (en) 2017-01-17
UY27550A1 (es) 2003-06-30
CA2467645A1 (en) 2003-06-05
WO2003045466A2 (en) 2003-06-05
HUP0600436A3 (en) 2010-12-28
IL162083A0 (en) 2005-11-20
ME00015B (me) 2010-06-10
PL371760A1 (en) 2005-06-27
IS7275A (is) 2004-05-21
TWI262794B (en) 2006-10-01
EP1455858A4 (en) 2006-02-15
JP4458240B2 (ja) 2010-04-28
US7829082B2 (en) 2010-11-09
US20060246050A1 (en) 2006-11-02
CN100478027C (zh) 2009-04-15
EA200400712A1 (ru) 2005-06-30
AR037437A1 (es) 2004-11-10
EA007594B1 (ru) 2006-12-29
MXPA04004948A (es) 2004-08-11
CO5580795A2 (es) 2005-11-30
ECSDI045123S (es) 2004-07-23
HUP0600436A2 (en) 2006-09-28
JP2005510302A (ja) 2005-04-21
KR20040054803A (ko) 2004-06-25
WO2003045466A3 (en) 2003-10-09
BR0215098A (pt) 2004-12-14

Similar Documents

Publication Publication Date Title
CY1109972T1 (el) Χρηση τοξινης αλλαντιασης για τη θεραπευτικη αγωγη του πονου της νεραλγιας
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ATE290890T1 (de) Wasserfreier, hydrophiler absorbierender wundverband
ATE409222T1 (de) Verfahren zur herstellung einer reversibel inaktiven, angesäuerten plasminzusammensetzung
ATE354384T1 (de) Perkutane zugangsvorrichtung
ES2170250T3 (es) Articulo absorbente desechable que tiene una lamina superior con locion y que contiene un emoliente y un agente inmovilizante de poliester de poliol.
ATE390078T1 (de) Mikrokatheter- und führungsdrahtsystem mit verbesserter schubfähigkeit und kontrolle
AR024874A1 (es) Composiciones bactericidas
UY27550A1 (es) Composición para catéter y usos de la misma
NO942211L (no) Acylerte sitratestere som persyreprecursorer
AR029655A1 (es) Mejoras en formulaciones en pasta
DE69221312D1 (de) Antimikrobielle Dialdehydzusammensetzungen und Methoden der Verwendung
BRPI0412413A (pt) composição de resina absorvente de água
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
DK261490D0 (da) New pharmaceutical compound
MX9701514A (es) Limpieza, desinfeccion y preparacion de lentes de contacto.
AR031401A1 (es) Adhesivo propicio para la piel y vendaje para heridas revestido con el mismo
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
DK106890A (da) Vandfrit hudrensemiddel og dets anvendelse
AR020455A1 (es) Composicion insecticida
DE3750493D1 (de) Flüssige sterilisierende Zusammensetzung.
NO20023630L (no) Anvendelse av retinoid-type forbindelser som antibakterielle midler
BR0313570A (pt) Agente, e, uso do mesmo
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen